Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Talar Tokatlian

Showing results (11-20 of 23) with videos related to

Pageof 3
Sort By:
Cancer Research Communications|March 2, 2023
Chimeric Antigen Receptors Directed at Mutant KRAS Exhibit an Inverse Relationship Between Functional Potency and Neoantigen SelectivityTalar Tokatlian, Grace E Asuelime, Martin S Naradikian, et al.
Molecular Immunology|October 5, 2020
Engineered T cells directed at tumors with defined allelic lossAgnes E Hamburger, Breanna DiAndreth, Jiajia Cui, et al.
Journal for Immunotherapy of Cancer|January 29, 2022
Mesothelin-specific CAR-T cell therapy that incorporates an HLA-gated safety mechanism selectively kills tumor cellsTalar Tokatlian, Grace E Asuelime, Jee-Young Mock, et al.
Scientific Reports|November 10, 2018
Enhancing Humoral Responses Against HIV Envelope Trimers via Nanoparticle Delivery with Stabilized Synthetic LiposomesTalar Tokatlian, Daniel W Kulp, Andrew A Mutafyan, et al.
Science (New York, N.Y.)|December 22, 2018
Innate immune recognition of glycans targets HIV nanoparticle immunogens to germinal centersTalar Tokatlian, Benjamin J Read, Christopher A Jones, et al.
Molecular Immunology|August 10, 2020
Structure-function relationships of chimeric antigen receptors in acute T cell responses to antigenHan Xu, Agnes E Hamburger, Jee-Young Mock, et al.
Cytotherapy|August 22, 2025
Detailed analysis of the effects of a NOT gate on activation and growth of T cellsYuta Ando, Jingli A Zhang, Ethan A McLeod, et al.
Biomaterials|June 6, 2021
Combined PET and whole-tissue imaging of lymphatic-targeting vaccines in non-human primatesJacob T Martin, Brittany L Hartwell, Sidath C Kumarapperuma, et al.
NPJ Vaccines|August 18, 2020
Targeting HIV Env immunogens to B cell follicles in nonhuman primates through immune complex or protein nanoparticle formulationsJacob T Martin, Christopher A Cottrell, Aleksandar Antanasijevic, et al.
Immunity|September 13, 2016
HIV Vaccine Design to Target Germline Precursors of Glycan-Dependent Broadly Neutralizing AntibodiesJon M Steichen, Daniel W Kulp, Talar Tokatlian, et al.
Pageof 3

Showing results (11-20 of 23) with videos related to

Sort By:
Pageof 3
Cancer Research Communications|March 2, 2023
Chimeric Antigen Receptors Directed at Mutant KRAS Exhibit an Inverse Relationship Between Functional Potency and Neoantigen SelectivityTalar Tokatlian, Grace E Asuelime, Martin S Naradikian, et al.
Molecular Immunology|October 5, 2020
Engineered T cells directed at tumors with defined allelic lossAgnes E Hamburger, Breanna DiAndreth, Jiajia Cui, et al.
Journal for Immunotherapy of Cancer|January 29, 2022
Mesothelin-specific CAR-T cell therapy that incorporates an HLA-gated safety mechanism selectively kills tumor cellsTalar Tokatlian, Grace E Asuelime, Jee-Young Mock, et al.
Scientific Reports|November 10, 2018
Enhancing Humoral Responses Against HIV Envelope Trimers via Nanoparticle Delivery with Stabilized Synthetic LiposomesTalar Tokatlian, Daniel W Kulp, Andrew A Mutafyan, et al.
Science (New York, N.Y.)|December 22, 2018
Innate immune recognition of glycans targets HIV nanoparticle immunogens to germinal centersTalar Tokatlian, Benjamin J Read, Christopher A Jones, et al.
Molecular Immunology|August 10, 2020
Structure-function relationships of chimeric antigen receptors in acute T cell responses to antigenHan Xu, Agnes E Hamburger, Jee-Young Mock, et al.
Cytotherapy|August 22, 2025
Detailed analysis of the effects of a NOT gate on activation and growth of T cellsYuta Ando, Jingli A Zhang, Ethan A McLeod, et al.
Biomaterials|June 6, 2021
Combined PET and whole-tissue imaging of lymphatic-targeting vaccines in non-human primatesJacob T Martin, Brittany L Hartwell, Sidath C Kumarapperuma, et al.
NPJ Vaccines|August 18, 2020
Targeting HIV Env immunogens to B cell follicles in nonhuman primates through immune complex or protein nanoparticle formulationsJacob T Martin, Christopher A Cottrell, Aleksandar Antanasijevic, et al.
Immunity|September 13, 2016
HIV Vaccine Design to Target Germline Precursors of Glycan-Dependent Broadly Neutralizing AntibodiesJon M Steichen, Daniel W Kulp, Talar Tokatlian, et al.
Pageof 3